Microglia CREB-Phosphorylation Mediates Amyloid-β-Induced Neuronal Toxicity

Area of Science:

• Neuroscience
• Molecular Biology
• Pathology

Background:

• Alzheimer's disease (AD) is characterized by amyloid-beta (Aβ) plaques.
• Mechanisms of Aβ neurotoxicity are not fully understood.

Purpose of the Study:

• Investigate the temporal effects and molecular mechanisms of Aβ-induced memory deficits.
• Elucidate the role of CREB phosphorylation and microglial activation in Aβ toxicity.

Main Methods:

• Intracerebroventricular infusion of Aβ42 in mice.
• Assessment of memory deficits, microglial activation, and CREB phosphorylation (pS133-CREB).
• Pharmacological inhibition of microglia (minocycline) and CREB phosphorylation (H89).
• Primary hippocampal neuron cultures treated with microglia-conditioned media.

Main Results:

• Aβ42 infusion caused transient memory deficits at 24 hours, not 7 days.
• Increased microglial pS133-CREB and activation observed at 24 hours.
• Aβ reduced neuronal pS133-CREB, IL-6, and MMP9, which was reversed by minocycline or H89.
• Aβ-conditioned media decreased neuronal GluN1/GluA2 levels, restored by PKA inhibition.

Conclusions:

• Aβ-induced memory deficits are transient and linked to microglial CREB phosphorylation.
• Microglial activation and subsequent CREB phosphorylation mediate Aβ neurotoxicity.
• Targeting microglial CREB phosphorylation may offer therapeutic potential for AD.